Who invested in Acclinate

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$11Mraised across 2 rounds since 2024, from 2 sources

$7.0MSeries A$3.5MRound

Latest round: Round, $3.5MApr 2026
Biggest round: $7.0MSeries A · May 2024
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026

$7.0MSeries A$3.5MRound

First round: Series A, $7.0M
Biggest round: $7.0M
Between rounds: 23 months

The rounds

Apr 2026
Round$3.5M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $3.5M sold, first sale Apr 2026
May 2024
Series A$7.0M4 new
Source recordedSEC filing: $6.0M sold, first sale May 2024

Founders and team

From Acclinate's own website: 1 founder, 2 on the team.

Tiffany WhitlowCo-Founder & Chief Development Officer

Rosemary RobinsonHead of Operations
Sara RoseHead of Business Intelligence

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2024Round2026

TechstarsGoogle for Startups

Gener8tor

Overline

Everyone who backed them

TechstarsVC firm1round

Google for StartupsAccelerator1round

Gener8torVC firm1round

OverlineVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Acclinate as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.